Market Closed -
NSE India S.E.
12:43:53 31/05/2024 BST
|
5-day change
|
1st Jan Change
|
126.6
INR
|
-0.47%
|
|
-5.10%
|
-12.87%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,301
|
1,103
|
629.7
|
1,533
|
5,061
|
3,322
|
Enterprise Value (EV)
1 |
1,633
|
1,323
|
662.9
|
1,291
|
4,779
|
3,020
|
P/E ratio
|
13.6
x
|
9.06
x
|
3.44
x
|
6.8
x
|
15.4
x
|
8.48
x
|
Yield
|
3.39%
|
2.67%
|
-
|
-
|
-
|
2.21%
|
Capitalization / Revenue
|
0.67
x
|
0.37
x
|
0.23
x
|
0.67
x
|
1.33
x
|
0.69
x
|
EV / Revenue
|
0.84
x
|
0.44
x
|
0.24
x
|
0.56
x
|
1.25
x
|
0.63
x
|
EV / EBITDA
|
8.82
x
|
5.75
x
|
2.3
x
|
3.69
x
|
9.37
x
|
5.19
x
|
EV / FCF
|
-7.35
x
|
9
x
|
3.73
x
|
5.67
x
|
-2,673
x
|
-41
x
|
FCF Yield
|
-13.6%
|
11.1%
|
26.8%
|
17.6%
|
-0.04%
|
-2.44%
|
Price to Book
|
1.65
x
|
1.29
x
|
0.63
x
|
1.25
x
|
3.25
x
|
1.73
x
|
Nbr of stocks (in thousands)
|
58,846
|
58,846
|
58,846
|
58,846
|
58,846
|
58,846
|
Reference price
2 |
22.10
|
18.75
|
10.70
|
26.05
|
86.00
|
56.45
|
Announcement Date
|
03/07/18
|
08/07/19
|
19/07/20
|
13/07/21
|
07/07/22
|
26/05/23
|
Fiscal Period: Marzo |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,947
|
2,998
|
2,732
|
2,289
|
3,815
|
4,821
|
EBITDA
1 |
185
|
230.2
|
287.6
|
349.8
|
510.1
|
581.7
|
EBIT
1 |
148.9
|
185
|
239.7
|
303.4
|
463.6
|
524.7
|
Operating Margin
|
7.65%
|
6.17%
|
8.78%
|
13.25%
|
12.15%
|
10.88%
|
Earnings before Tax (EBT)
1 |
144.7
|
159.6
|
243.5
|
314.8
|
460.7
|
552.1
|
Net income
1 |
95.76
|
121.9
|
183.3
|
225.4
|
328.9
|
391.8
|
Net margin
|
4.92%
|
4.06%
|
6.71%
|
9.85%
|
8.62%
|
8.13%
|
EPS
2 |
1.627
|
2.070
|
3.110
|
3.830
|
5.588
|
6.657
|
Free Cash Flow
1 |
-222.2
|
147
|
177.7
|
227.7
|
-1.788
|
-73.64
|
FCF margin
|
-11.42%
|
4.9%
|
6.51%
|
9.95%
|
-0.05%
|
-1.53%
|
FCF Conversion (EBITDA)
|
-
|
63.86%
|
61.78%
|
65.1%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
120.66%
|
96.94%
|
101%
|
-
|
-
|
Dividend per Share
2 |
0.7500
|
0.5000
|
-
|
-
|
-
|
1.250
|
Announcement Date
|
03/07/18
|
08/07/19
|
19/07/20
|
13/07/21
|
07/07/22
|
26/05/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
332
|
220
|
33.3
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
242
|
282
|
302
|
Leverage (Debt/EBITDA)
|
1.795
x
|
0.9544
x
|
0.1157
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-222
|
147
|
178
|
228
|
-1.79
|
-73.6
|
ROE (net income / shareholders' equity)
|
12.8%
|
14.9%
|
19.7%
|
20.2%
|
23.6%
|
22.5%
|
ROA (Net income/ Total Assets)
|
6.74%
|
7.88%
|
10.1%
|
12%
|
14.7%
|
13.3%
|
Assets
1 |
1,421
|
1,546
|
1,809
|
1,882
|
2,234
|
2,947
|
Book Value Per Share
2 |
13.40
|
14.50
|
17.00
|
20.90
|
26.50
|
32.60
|
Cash Flow per Share
2 |
0.0600
|
0.9300
|
0.0600
|
2.170
|
1.170
|
2.000
|
Capex
1 |
300
|
95.2
|
25.5
|
51
|
205
|
205
|
Capex / Sales
|
15.4%
|
3.17%
|
0.93%
|
2.23%
|
5.36%
|
4.24%
|
Announcement Date
|
03/07/18
|
08/07/19
|
19/07/20
|
13/07/21
|
07/07/22
|
26/05/23
|
|
1st Jan change
|
Capi.
|
---|
| -12.87% | 89.23M | | +2.46% | 102B | | -9.22% | 60.79B | | +74.76% | 48.86B | | +13.97% | 37.96B | | +4.56% | 32.37B | | +14.72% | 20.64B | | +11.17% | 16.58B | | +8.81% | 13.93B | | -3.19% | 13.25B |
Other Commodity Chemicals
|